Navegando por Palavras-chave "premenstrual syndrome"

Agora exibindo 1 - 2 de 2
  • Nenhuma Miniatura disponível
    Item
    Somente Metadadados
    Clinical diagnostic criteria for premenstrual syndrome and guidelines for their quantification for research studies
    (Informa Healthcare, 2007-03-01) Halbreich, Uriel; Backstrom, Torbjorn; Eriksson, Elias; O'Bren, Shawn; Calil, Helena [UNIFESP]; Ceskova, Eva; Dennerstein, Lorraine; Douki, Saida; Freeman, Ellen; Genazzani, Andrea; Heuser, Isabella; Kadri, Nadia; Rapkin, Andrea; Steiner, Meir; Wittchen, Hans-Ulrich; Yonkers, Kimberly; SUNY Buffalo; World PSychiat Assoc; Noorland Univ Hosp; Univ Gothenburg; Keele Univ; Royal Coll Obstetricians & Gynaecologists; Universidade Federal de São Paulo (UNIFESP); Masaryk Univ; Fac Hosp; Univ Melbourne; Hosp Razi; Univ Penn; Univ Pisa; Charite; Idn Rushd Univ PSychiat Ctr; Univ Calif Los Angeles; McMaster Univ; Max Planck Inst Psychiat; Tech Univ Dresden; Yale Sch Med
    Premenstrual syndrome (PMS) encompasses a variety of symptoms appearing during the luteal phase of the menstrual cycle. Although PMS is widely recognized, the etiology remains unclear and it lacks definitive, universally accepted diagnostic criteria. To address these issues an international multidisciplinary group of experts evaluated the current definitions and diagnostic criteria of PMS and premenstrual dysphoric disorder (PMDD). Following extensive correspondence, a consensus meeting was held with the aim of producing updated diagnostic criteria for PMS and guidelines for clinical and research applications. This report presents the conclusions and recommendations of the group. It is hoped that the criteria proposed by the group will become widely accepted and eventually be incorporated into the next edition of the World Health Organization's International Classification of Diseases (ICD-11). It is also hoped that the proposed guidelines for quantification of criteria will be used by clinicians and investigators to facilitate diagnostic uniformity in the field as well as adequate treatment modalities when warranted.
  • Imagem de Miniatura
    Item
    Acesso aberto (Open Access)
    Relationship between Anxiety and Interleukin 10 in Female Soccer Players with and Without Premenstrual Syndrome (PMS)
    (Federacao Brasileira Soc Ginecologia & Obstetricia-Febrasgo, 2017) Foster, Roberta [UNIFESP]; Vaisberg, Mauro [UNIFESP]; de Araujo, Maita Poli [UNIFESP]; Martins, Marcia Aparecida [UNIFESP]; Capel, Tiago [UNIFESP]; Lacerda Bachi, Andre Luis; Katalin de Jarmy-Di Bella, Zsuzsanna Ilona [UNIFESP]
    Objective To investigate the level of anxiety and its relationship with interleukin (IL)10 (anti inflammatory cytokine that modulates mood swings) in a group of female soccer players. Methods Fifty-two eumenorrheic soccer players were evaluated (age 19.8 +/- 4.7 years). The presence of premenstrual syndrome (PMS) and phases of the menstrual cycle were determined by a daily symptomreport (DSR) kept for 3 consecutivemonths. The concentration of cytokine IL-10 was determined from urine samples collected at four moments: at the follicular and luteal phases of the menstrual cycle, and before (pre) and after (post) the simulated game, and it was quantified by flow cytometry (Luminex xMAP - EMDMillipore, Billerica, MA, USA). The level of anxietywas determined through the BAI anxiety questionnaire answered by all athletes at the same time of the urine collection. The Student t-test, analysis of variance (ANOVA) and Pearson correlation with significance level at 5% were used for data analysis. Results We showed that the prevalence of PMS among female soccer players is similar to that reported in the literature. In addition, we showed that the group withPMS has a higher level of anxiety compared with group without PMS (p = 0.002). Interleukin-10 analysis in players without PMS revealed that there was a significant decrease in the level of this cytokine before the game during the luteal phase when compared with the follicular phase (p < 0.05). The correlation analysis between IL-10 and anxiety showed a negative correlation post-game in the luteal phase in the group without PMS (p = 0.02; r = -0.50) and a positive correlation post-game in the luteal phase in PMS group (p = 0.04; r = 0.36). Conclusion Our results suggest that IL-10 may contribute to reduce anxiety in the group without PMS. This could be attributed to the fact that no IL-10 variation was observed in the group with PMS, which presented higher anxiety symptoms when compared with the group without PMS.